Torrent Pharma slips over 3.25% after its Gujarat facility receives Form 483 with 5 observations from US FDA
Torrent Pharmaceuticals said on Wednesday that its that it Indrad, Gujarat-based manufacturing facility had received Form 483 from the US FDA. The pharma firm said that the US FDA had conducted a pre-approval inspection (PAI) and a GMP inspection at the its manufacturing facility in Indrad, Gujarat, from June 3 to June 12.
)
Torrent Pharma Share Price: Torrent Pharmaceuticals Ltd slipped by over 3.25 per cent on BSE on Thursday (June 13, 2024) as the large-cap firm's Gujarat-based manufacturing facility received Form 483 with five observations from the United States Food and Drug Administration (US FDA).
Torrent Pharmaceuticals shares that closed trading at Rs 2, 894.45 each a day ago slipped by 3.26 per cent to Thursday's low of Rs 2,800.05 apiece.
Torrent Pharmaceuticals shares were trading lower by 0.88 per cent, or Rs 25.55, at Rs 2,868.90 at 9:50 am on Thursday.
The stock slipped a day after the firm touched its 52-week high of Rs 2,919.95.
Torrent Pharmaceuticals said on Wednesday that its that it Indrad, Gujarat-based manufacturing facility had received Form 483 from the US FDA.
The pharma firm said that the US FDA had conducted a pre-approval inspection (PAI) and a GMP inspection at the its manufacturing facility in Indrad, Gujarat, from June 3 to June 12.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
10:01 AM IST
Torrent Pharma shares jump 7% post strong Q4 results; should you buy, or sell pharma stock?
Torrent Pharma Q4 Results Preview: Drug maker likely to clock 56% jump in net profit, margin may expand by 300 bps
Torrent Pharma Q3 Results: PAT jumps 52% to Rs 443 crore